The Quality Assurance Section is responsible for establishing and maintaining a comprehensive quality management system (QMS) encompassing every aspect of vaccine and diagnostic production. QA ensures compliance with Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and all relevant national standards.
The section also monitors documentation, validation, deviation control, and product release authorization to ensure continuous improvement and traceability.
The QMS implemented by the QA Section covers documentation control, deviation handling, change management, and product recall procedures. Each process is designed to ensure full compliance with ISO 9001 and regulatory guidelines for veterinary biological production.
The QA Section works in close coordination with Quality Control (QC), production, and R&D divisions to ensure that all products meet predefined acceptance criteria before release. QA also participates in external audits and proficiency testing to benchmark institutional quality standards.
Upholding transparency, accountability, and continuous improvement, the Quality Assurance Section remains committed to delivering biological products that meet the expectations of farmers, veterinarians, and regulatory authorities alike.